elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q44038372-97E719FA-3C31-4AEC-B0DC-CDC813D8D787
Q44038372-97E719FA-3C31-4AEC-B0DC-CDC813D8D787
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44038372-97E719FA-3C31-4AEC-B0DC-CDC813D8D787
Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33.
P2860
Q44038372-97E719FA-3C31-4AEC-B0DC-CDC813D8D787
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44038372-97E719FA-3C31-4AEC-B0DC-CDC813D8D787
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4c72c9f63aab0e12c6f135c6d01014505de2f94
P2860
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial